ARCHIVES

In Brief: Taxol Development Is NCI ‘Emergency Priority’, Dodd To Focus ACS Effort On Breast Screening

This article is from The Cancer Letter archive.

Vol. 16 No. 47 | December 7, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

St. Vincent Of NYC Joins Funded CCOPS Spurr To Be Professor Emeritus; UCOG, Still Unfunded, Still Active

May 1, 1987

Congress Deluged With Protests From Biomedical Researchers Over Grants Reduction, Budget Cuts

February 15, 1985

Development Of New Screening System For Antimetastasis Drugs Approved

June 25, 1982